Veramarx Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Veramarx General Information

Description

Provider of molecular diagnostic service designed to detect Lyme disease. The company leverages multi-analyte and algorithm-based technology that measures multiple biomarkers known to occur soon after Lyme disease infections, enabling doctors to diagnose early-stage diseases and recover patients.

Contact Information

Website
www.veramarx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 12635 East Montview Boulevard
  • Aurora, CO 80045
  • United States
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Vertical(s)
TMT, HealthTech
Corporate Office
  • 12635 East Montview Boulevard
  • Aurora, CO 80045
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Veramarx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 20-Apr-2025 Completed Out of Business
4. Accelerator/Incubator 23-Feb-2017 Completed Generating Revenue
3. Angel (individual) 01-Jan-2016 Completed Startup
2. Early Stage VC (Series A) 01-May-2015 $400K $400K Completed Startup
1. Capitalization 01-Jul-2013 Completed Startup
To view Veramarx’s complete valuation and funding history, request access »

Veramarx Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • Pending

  • Expiring in next 12 mo

Veramarx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3400441-A1 Biomarker signatures for lyme disease differentiation and methods of use thereof Inactive 06-Jan-2016
EP-3400441-A4 Biomarker signatures for lyme disease differentiation and methods of use thereof Inactive 06-Jan-2016
US-10725038-B2 Biomarker signatures for lyme disease differentiation and methods of use thereof Inactive 06-Jan-2016
US-20190033310-A1 Biomarker signatures for lyme disease differentiation and methods of use thereof Active 06-Jan-2016
WO-2017119881-A1 Biomarker signatures for lyme disease differentiation and methods of use thereof Inactive 06-Jan-2016 G01N33/56911
To view Veramarx’s complete patent history, request access »

Veramarx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Veramarx FAQs

  • When was Veramarx founded?

    Veramarx was founded in 2012.

  • Where is Veramarx headquartered?

    Veramarx is headquartered in Aurora, CO.

  • What is the size of Veramarx?

    Veramarx has 3 total employees.

  • What industry is Veramarx in?

    Veramarx’s primary industry is Laboratory Services (Healthcare).

  • Is Veramarx a private or public company?

    Veramarx is a Private company.

  • What is Veramarx’s current revenue?

    The current revenue for Veramarx is .

  • How much funding has Veramarx raised over time?

    Veramarx has raised $640K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process